ICAM1 and breast cancer: The normal growth of ICAM-1-deficient breast cancer cells in primary tumors was associated with the normal tumor content of various CD45+ immune cells recruited by primary E0771 tumors with a small reduction in the DC and B-cell content in the draining LNs of the breast cancer tumors.